BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30804107)

  • 1. Malignant Transformation of Fanconi Anemia Complementation Group D2-deficient (
    Zhang X; Fisher R; Shields D; Hou W; Franicola D; Wang H; Epperly MW; Rigatti L; Greenberger JS
    In Vivo; 2019; 33(2):303-311. PubMed ID: 30804107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of malignant plasmacytoma cell lines from K14E7 Fancd2-/- mouse long-term bone marrow cultures.
    Zhang X; Hou W; Epperly MW; Rigatti L; Wang H; Franicola D; Sivanathan A; Greenberger JS
    Oncotarget; 2016 Oct; 7(42):68449-68472. PubMed ID: 27637088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-risk human papillomavirus oncogenes disrupt the Fanconi anemia DNA repair pathway by impairing localization and de-ubiquitination of FancD2.
    Khanal S; Galloway DA
    PLoS Pathog; 2019 Feb; 15(2):e1007442. PubMed ID: 30818369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of Wnt signaling pathway by human papillomavirus E6 and E7 oncogenes in HPV16-positive oropharyngeal squamous carcinoma cells.
    Rampias T; Boutati E; Pectasides E; Sasaki C; Kountourakis P; Weinberger P; Psyrri A
    Mol Cancer Res; 2010 Mar; 8(3):433-43. PubMed ID: 20215420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HPV16 oncogenes E6 or/and E7 may influence the methylation status of RASSFIA gene promoter region in cervical cancer cell line HT-3.
    Yin F; Wang N; Wang S; Yu F; Sun X; Yu X; Luo B; Zhao C; Wang Y
    Oncol Rep; 2017 Apr; 37(4):2324-2334. PubMed ID: 28260046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc finger nucleases targeting the human papillomavirus E7 oncogene induce E7 disruption and a transformed phenotype in HPV16/18-positive cervical cancer cells.
    Ding W; Hu Z; Zhu D; Jiang X; Yu L; Wang X; Zhang C; Wang L; Ji T; Li K; He D; Xia X; Liu D; Zhou J; Ma D; Wang H
    Clin Cancer Res; 2014 Dec; 20(24):6495-503. PubMed ID: 25336692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA interference against HPV16 E7 oncogene leads to viral E6 and E7 suppression in cervical cancer cells and apoptosis via upregulation of Rb and p53.
    Sima N; Wang W; Kong D; Deng D; Xu Q; Zhou J; Xu G; Meng L; Lu Y; Wang S; Ma D
    Apoptosis; 2008 Feb; 13(2):273-81. PubMed ID: 18060502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Induction of human oral carcinoma by human papillomavirus 16 E6/E7 and TPA].
    Zhao J; Cao ZY; Sun YT; Liao QP; Du HJ; Zeng Y
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2003 Sep; 17(3):234-6. PubMed ID: 15340565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Honeybee venom possesses anticancer and antiviral effects by differential inhibition of HPV E6 and E7 expression on cervical cancer cell line.
    Kim YW; Chaturvedi PK; Chun SN; Lee YG; Ahn WS
    Oncol Rep; 2015 Apr; 33(4):1675-82. PubMed ID: 25633640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical role for D-type cyclins in cellular transformation induced by E6/E7 of human papillomavirus type 16 and E6/E7/ErbB-2 cooperation.
    Yasmeen A; Hosein AN; Yu Q; Al Moustafa AE
    Cancer Sci; 2007 Jul; 98(7):973-7. PubMed ID: 17489986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteins.
    Park JW; Shin MK; Pitot HC; Lambert PF
    PLoS One; 2013; 8(9):e75056. PubMed ID: 24086435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bypass of senescence, immortalization, and transformation of human hematopoietic progenitor cells.
    Akimov SS; Ramezani A; Hawley TS; Hawley RG
    Stem Cells; 2005 Oct; 23(9):1423-33. PubMed ID: 16144874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer.
    Park JW; Pitot HC; Strati K; Spardy N; Duensing S; Grompe M; Lambert PF
    Cancer Res; 2010 Dec; 70(23):9959-68. PubMed ID: 20935219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
    Jung YS; Kato I; Kim HR
    Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiologic differences between bone marrow stromal and hematopoietic progenitor cell lines from Fanconi Anemia (Fancd2(-/-)) mice.
    Berhane H; Epperly MW; Goff J; Kalash R; Cao S; Franicola D; Zhang X; Shields D; Houghton F; Wang H; Wipf P; Parmar K; Greenberger JS
    Radiat Res; 2014 Jan; 181(1):76-89. PubMed ID: 24397476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. E6 and E7 gene silencing results in decreased methylation of tumor suppressor genes and induces phenotype transformation of human cervical carcinoma cell lines.
    Li L; Xu C; Long J; Shen D; Zhou W; Zhou Q; Yang J; Jiang M
    Oncotarget; 2015 Sep; 6(27):23930-43. PubMed ID: 26329329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies.
    Spardy N; Duensing A; Hoskins EE; Wells SI; Duensing S
    Cancer Res; 2008 Dec; 68(23):9954-63. PubMed ID: 19047177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
    McFarlane M; MacDonald AI; Stevenson A; Graham SV
    J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of HPV16 E6/E7 mediated HIF-1α upregulation of GLUT1 expression in lung cancer cells.
    Fan R; Hou WJ; Zhao YJ; Liu SL; Qiu XS; Wang EH; Wu GP
    Tumour Biol; 2016 Apr; 37(4):4655-63. PubMed ID: 26508030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cervical cancer cell growth in vitro and in vivo by lentiviral-vector mediated shRNA targeting the common promoter of HPV16 E6 and E7 oncogenes.
    Zhou J; Li B; Peng C; Wang F; Fu Z; Zhou C; Hong D; Ye F; Lü W; Xie X
    Antiviral Res; 2013 May; 98(2):305-13. PubMed ID: 23523766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.